Clinical trial
Clinical Evaluation of the p64 MW HPC and the p48 MW HPC Flow Diverters in an Observational Registry
NCT04305704 is registered in ClinicalTrials.gov with Phenox GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Evaluation of the p64 MW HPC and the p48 MW HPC Flow Diverters in an Observational Registry
- Lead sponsor
- Phenox GmbH
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 8, 2020
- Completion date
- December 30, 2023
- Enrollment
- 90 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.